Association between vitamin D receptor gene polymorphisms and susceptibility to chronic kidney disease and periodontitis

被引:40
作者
de Souza, Cleber Machado [1 ]
Braosi, Ana Paula Ribeiro [1 ]
Luczyszyn, Sonia Mara [1 ]
Avila, Andrea Rodrigues [1 ]
de Brito, Rui Barbosa, Jr. [1 ]
Ignacio, Sergio Aparecido [1 ]
Probst, Christian Macagnan [1 ]
Riella, Miguel Carlos [1 ]
Sotomaior, Vanessa Santos [1 ]
Mira, Marcelo Tavora [1 ]
Pecoits-Filho, Roberto [1 ]
Trevilatto, Paula Cristina [1 ]
机构
[1] Pontificia Univ Catolica Parana, Ctr Hlth & Biol Sci, BR-80215901 Curitiba, Parana, Brazil
关键词
end-stage renal disease; periodontitis; vitamin D receptor; genetic polymorphisms;
D O I
10.1159/000109235
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Chronic kidney disease (CKD) and periodontitis (PD) are serious public-health concerns. Vitamin D is a fat-soluble steroid hormone that interacts with its nuclear receptor (VDR) to regulate a variety of biological processes, such as bone metabolism, immune response modulation and transcription of several genes involved in CKD and PD disease mechanisms. The aim of this work was to investigate the association between polymorphisms in the VDR gene and end-stage renal disease (ESRD) and PD. Methods: 222 subjects with and without ESRD (in hemodialysis) were divided into groups with and without PD. Polymorphisms TaqI and BsmI in the VDR gene were analyzed by PCR restriction fragment length polymorphism. The significance of differences in allele, genotype and haplotype frequencies between groups was assessed by the chi(2) test (p value < 0.05) and odds ratio (OR). Results: Allele G was associated with protection against ESRD: groups without versus with ESRD (GG) X (GA+AA): OR = 2.5, 95% CI = 1.4-4.6, p = 0.00; (G X A): OR = 1.5, 95% CI = 1.0-2.3, p = 0.02; (TG + CG) X ( TA + CA): OR = 1.5, 95% CI = 1.0-2.3, p = 0.02. No association was observed between the study polymorphisms and susceptibility to or protection against PD. Conclusion: Allele G of the VDR BsmI polymorphism was associated with protection against ESRD.
引用
收藏
页码:411 / 419
页数:9
相关论文
共 71 条
[31]   C-reactive protein and end-stage renal disease [J].
Lacson, E ;
Levin, NW .
SEMINARS IN DIALYSIS, 2004, 17 (06) :438-448
[32]  
Langdahl BL, 2000, EUR J CLIN INVEST, V30, P608
[33]  
LEO H, 1963, ACTA ODONTOL SCAND, V21, P533
[34]   A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation [J].
Levey, AS ;
Bosch, JP ;
Lewis, JB ;
Greene, T ;
Rogers, N ;
Roth, D .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :461-+
[35]  
Li YC, 2002, J CLIN INVEST, V110, P229, DOI [10.1172/JCI0215219, 10.1172/JCI200215219]
[36]   The pleiotropic actions of vitamin D [J].
Lin, R ;
White, JH .
BIOESSAYS, 2004, 26 (01) :21-28
[37]   Secondary hyperparathyroidism in chronic renal failure: Pathogenic and clinical aspects [J].
Llach, F ;
Forero, FV .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (05) :S20-S33
[38]  
Lundin AC, 1999, CANCER RES, V59, P2332
[39]   INTERACTIONS OF 1,25-DIHYDROXYVITAMIN-D3 AND THE IMMUNE-SYSTEM [J].
MANOLAGAS, SC ;
PROVVEDINI, DM ;
TSOUKAS, CD .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1985, 43 (2-3) :113-122
[40]   IDENTIFICATION AND REGULATION OF 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR ACTIVITY AND BIOSYNTHESIS OF 1,25-DIHYDROXYVITAMIN-D3 - STUDIES IN CULTURED BOVINE AORTIC ENDOTHELIAL-CELLS AND HUMAN DERMAL CAPILLARIES [J].
MERKE, J ;
MILDE, P ;
LEWICKA, S ;
HUGEL, U ;
KLAUS, G ;
MANGELSDORF, DJ ;
HAUSSLER, MR ;
RAUTERBERG, EW ;
RITZ, E .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (06) :1903-1915